Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? is an episode from GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD. Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Nec...
This episode belongs to GRACEcast Lung Cancer Video.
Use the player on this page to stream the episode online.
Published Jul 22, 2014, 02:27 long, audio available.
Continue listening to more episodes from GRACEcast Lung Cancer Video.
Jul 29, 2014 - 01:55
Jul 24, 2014 - 02:03
Jul 20, 2014 - 04:40
Jul 15, 2014 - 03:15
Jul 13, 2014 - 07:22
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
You can listen to Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? online on Radio and Podcast. Open the player on this page to stream the available audio.
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? is an episode from GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD.
This episode is 02:27 long.
This episode was published on Jul 22, 2014.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from GRACEcast Lung Cancer Video when more episodes are available from the podcast feed.